#Aerospace #supplychains saw a 27% increase in risk events in 2024, while #pharmaceutical R&D costs rose 14%.

#Manufacturing faces a parallel challenge with raw material shortages delaying production schedules globally.

Are #riskmanagement strategies in these sectors keeping pace with growing complexity?